Drugs Made In America Acquisition (DMII) Equity Ratio (2024 - 2025)
Drugs Made In America Acquisition (DMII) reported Equity Ratio of 0.04 for Q4 2025, up 95.84% year-over-year from 0.02 in Q4 2024, and down 2.05% on a QoQ basis from 0.03 in Q3 2025.
Drugs Made In America Acquisition (DMII) has 2 years of Equity Ratio data on file, last reported at 0.04 in Q4 2025.
- Quarterly Equity Ratio rose 95.84% year-over-year to 0.04 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.04 (up 95.84% YoY) and the FY2025 annual result came in at 0.04, up 95.84% from the prior year.
- Equity Ratio fell to 0.04 in Q4 2025 per DMII's latest filing, from 0.03 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.03 in Q3 2025 and bottomed at 0.85 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -0.03 |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | -0.04 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | -0.04 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | -0.04 |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | -0.08 |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | -0.06 |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | -0.03 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | -0.05 |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | -0.03 |
| 10 | Drugs Made In America Acquisition | 128.97 Mn | 128.97 Mn | - | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.04 |
| Sep 30, 2025 | -0.03 |
| Dec 31, 2024 | -0.85 |